Abstract-Fertilized chicken eggs were injected with high doses of individual polychlorinated biphenyl (PCB) congeners (0.5 g of PCB 77, 9.8 g of PCB 153, or 10.9 g of PCB 180) before incubation to investigate the structure-specific uptake of these compounds by the embryo and their accumulation in brain and liver tissue. In accordance with earlier publications, a gradual uptake and accumulation of these compounds was observed during the last week of embryonic development. The PCB uptake and distribution to the specific tissues did not appear to be structure dependent. Wet-weight liver PCB concentrations (18, 266, and 278 ng/g at hatching for PCB 77, PCB 153, and PCB 180, respectively) were consistently two-to fourfold higher than carcass levels (7 ng/g of PCB 77, 117 ng/g of PCB 153, and 81 ng/g of PCB 180 at hatching). Whereas liver and carcass concentrations increased exponentially between day 13 of incubation and hatching, PCB levels in brain tissue remained unaltered (range, 0.6-1.0 ng/g of PCB 77 and 8-12 ng/g of PCB 153 and PCB 180 throughout the last week of incubation). Lipid analysis of the organs suggested that the lipid composition of brain may be an important factor explaining the low PCB accumulation in this tissue.
INTRODUCTION
Polychlorinated biphenyls (PCBs) are a class of 209 discrete chemical compounds in which 1 to 10 chlorine atoms are attached to a biphenyl backbone. Through both use and disposal, complex mixtures of PCBs have entered the environment, in which they persist because of their physicochemical properties. These ubiquitous environmental pollutants bioaccumulate in both humans and animals, and they elicit a wide range of adverse effects, including immunotoxicity, endocrine disruption, neurotoxicity, and cancer [1] [2] [3] . Epidemiological studies have shown that PCBs and related compounds may affect neurological development and impair human cognitive functions (for review, see [4, 5] ). The toxicity of PCBs varies with the specific congener, the species exposed, and the age of the animal [1, 6, 7] . Different animal models have been used to study the effects of exposure to PCBs [2, 7] . For the study of the developmental toxicity of PCBs, avian embryos have certain advantages. They are relatively large and easier to access and manipulate during development compared to mammals, which develop in utero. Because avian embryos develop in ovo, no biochemical interactions with the mother occur, which makes it easier to dose the compound of interest and to evaluate its direct effects. Compared to rats, chickens may provide a superior model to assess the effects of PCBs on the thyroid-hormone axis during development, because unlike in rats, a substantial part of the thyroid system development of both chickens and humans is already completed at birth [8] . Based on comparative avian studies, it also was concluded that chickens display a very high sensitivity to the embryotoxic effects of dioxins and PCBs [9] .
The aims of the present study were to investigate the uptake of individual PCB congeners by chicken embryos and to eval-uate the method of exposure (i.e., injection) for future use in neurotoxicity and endocrine-disruption studies. Liver and brain are important target organs for some of the adverse effects induced by PCBs, but to our knowledge, PCB accumulation in these tissues was not investigated in earlier uptake studies [10, 11] . Therefore, PCB concentrations were determined in brain and liver tissues and in the homogenate of the remaining embryo/chick carcass on several days during the last week of in ovo development. Because the lipid content of tissues is considered to be an important determinant for the distribution and accumulation of the lipophilic PCBs, brain and liver samples also were analyzed for total lipid content and lipid composition.
MATERIALS AND METHODS

Exposure
Whereas 3,3Ј,4,4Ј-tetrachlorobiphenyl (PCB 77) was included in the tests for its dioxin-like properties, 2,2Ј,4,4Ј,5,5Ј-hexachlorobiphenyl (PCB 153) and 2,2Ј,3,4,4Ј,5,5Ј-heptachlorobiphenyl (PCB 180) were selected because they represent two of the most prevalent congeners detected in environmental samples. Neat crystals of PCB 77 were purchased from Dr. Ehrenstorfer (Augsburg, Germany), whereas PCB 153 and PCB 180 were obtained from Sigma-Aldrich (Bornem, Belgium). The individual PCB congeners were solubilized in hexane and added to arachis oil, after which the solvent was evaporated. Actual concentrations of the three final dosing solutions were determined at 0.5 g of PCB 77, 9.8 g of PCB 153, and 10.9 g of PCB 180 per 100 l of oil. Fertilized broiler chicken eggs (Gallus domesticus, Ross strain) were obtained from Avibel (Zoersel, Belgium), and 100 l of one of the PCB solutions were injected directly in the egg yolk just before the start of incubation (day 1). For this purpose, a small hole was made at the air chamber of the egg with a dentist drill and then sealed with air-permeable tape (Albupore; Smith-Nephew S.A., Le Mans, France) after injection. Eggs used for control purposes were injected with 100 l of unfortified oil. The eggs were then incubated in a forced-draft laboratory incubator at 37.8ЊC (vapor pressure, 30 mm Hg) under continuous lighting and were automatically rotated 45Њ once every hour. Samples were taken on days 13, 15, 18, and 20 of incubation and just after hatching (i.e., day 21). The animals were killed by decapitation, and brain and liver tissues were collected and pooled. The organs and the remaining bodies (brain and liver excluded; hereafter referred to as carcass) were stored at Ϫ20ЊC before analysis. Animals that died prematurely during the incubation were not included for analysis. Approval for the experimental protocols was obtained from the Leuven University Animal Ethics Committee.
PCB analysis
Standard solutions of PCBs for chemical analysis were obtained from Dr. Ehrenstorfer (PCB 46, PCB 143, PCB-mix 3 containing PCB 153, and PCB 180) and Ultra Scientific (PCB 77; North Kingstown, RI, USA). All other chemicals were purchased from Merck (Darmstadt, Germany). Samples of brain (0.7-1.9 g) and liver (0.3-1.2 g) as well as aliquots of the homogenized carcasses (3.7-8.6 g for PCB 77 and 0.4-3.5 g for PCB 153 and PCB 180) were weighed and ground with sodium sulfate. Either PCB 46 or PCB 143 was added as internal standard (IS) for the quantification of PCB 77 and of PCB 153 and PCB 180, respectively. The samples were subsequently extracted and analyzed as described elsewhere [12] . Procedural blanks, control samples, and spiked control samples were analyzed for quality-assurance/quality-control purposes. Spiking recoveries ranged from 106 to 132% for PCB 77, 99 to 113% for PCB 153, and 90 to 111% for PCB 180. The limit of quantification was set at 0.3 ng/sample. Polychlorinated biphenyl concentrations measured in the samples were corrected for spiking recoveries and background concentrations in the corresponding control samples.
The presence of hydroxylated PCB metabolites (HO-PCBs) was investigated in the liver of 18-and 20-d-old chicken embryos. All HO-PCBs are abbreviated as proposed by Maervoet et al. [13] . A standard solution of 4Ј-HO-CB 159 (IS) was acquired from Accustandard (New Haven, CT, USA). Sandau. Sample (Ϯ1 g) preparation and extraction were identical to those for PCBs, with the exception that 4Ј-HO-CB 159 was used as IS. After methylation with diazomethane [14] , the extracts were applied to an acid silica column, which was consecutively washed with 10 ml of hexane. Subsequently, the methylated HO-PCBs (MeO-PCBs) were eluted with 8 ml of dichloromethane, and the eluate was evaporated by a gentle nitrogen stream. The compounds were reconstituted in 70 l of iso-octane, of which 2 l were injected. For metabolites of PCB 77, a gas chromatography/mass spectrometer (Agilent, Palo Alto, CA, USA) equipped with a 30-m ϫ 0.25-mm ϫ 0.25-m, DB-1ms capillary column (J&W Scientific, Folsom, CA, USA) was operated in electron-ionization mode. The identification was based on retention time and on individual chromatograms for analyte-specific ions (MeO-trichlorophenyl: m/ z ϭ 271, 286, and 290; MeO-tetrachloropbiphenyl: m/z ϭ 307, 320, and 322; IS: m/z 375, 390, and 392). For metabolites of PCB 153 and PCB 180, a gas chromatography/mass spectrometer equipped with a 25-m ϫ 0.22-mm ϫ 0.25-m HT-8 (high temperature, 8% phenylpolysiloxane) capillary column (Scientific Glass Engineering/SGE, Zulte, Belgium) was used in electron-capture, negative-ionization mode. The identification was based on retention time and on individual chromatograms for analyte-specific ions (MeO-hexachlorobiphenyl: m/z ϭ 375, 390, and 392; MeO-heptachlorobiphenyl: m/z ϭ 409, 424, and 426). Limits of quantification were determined at 0.1 ng/ g tissue for the tri-and tetrachlorinated metabolites and at 0.02 ng/g tissue for the hexa-and heptachlorinated compounds.
Lipid analysis
Approximately 20 mg of dry ground tissue were extracted (15 min at 4ЊC) twice with 1 ml of a chloroform:methanol (2: 1, v/v) mixture, and the supernatants were combined. Two milliliters of chloroform and 1 ml of a 0.88% aqueous potassium chloride solution were added, and the mixture was thoroughly shaken and centrifuged. The upper aqueous layer was aspirated, and one ml of a methanol:0.88% potassium chloride solution (1:1, v/v) mixture was added to the lower phase. After vortex mixing and centrifugation (3 min, 6,400 g), the upper aqueous phase was aspirated together with the interphase containing the proteins. The lower, organic phase was evaporated at 40ЊC under a nitrogen flow. A column was made by wetting 500 mg of silica gel 60 (diameter, 0.063-0.2 mm; MacheryNagel, Düren, Germany) with chloroform:acetic acid (100:1, v/v) in a pipette tip. The dried lipid fraction was solubilized in 2 ml of a chloroform:acetic acid (100:1, v/v) mixture and applied to the silica gel column, and three fractions were eluted. A first fraction, containing the neutral/nonpolar lipids (e.g., triglycerides, sterols, and steryl esters), was eluted with 10 ml of chloroform. Glycolipids (sphingolipids) were collected in a second fraction by elution with 5 ml of acetone and 5 ml of an acetone:methanol:acetic acid (100:5:1, v/v) mixture. Finally, a third fraction, containing the phospholipids, was eluted with 7.5 ml of a methanol:chloroform:water (100:50:40, v/v) mixture. To this last fraction, 2.25 ml of chloroform and 3 ml of water were added to obtain a phase separation. All the organic phases were evaporated under a nitrogen flow, and the weight of the three fractions was determined.
Statistical analysis
Statistical analysis was performed with SPSS 11.0 statistical software (SPSS, Chicago, IL, USA). Data were tested for normal distribution (Kolmogorov-Smirnov test) and homogeneity of variance (Levene test). The relative uptake of the three PCB congeners in the embryos was compared, and differences between the PCB levels in the tissues on the various sampling days were examined by analysis of variance and the Scheffé post-hoc test. Outliers were identified with Dixon's test and removed. The impact of the PCB treatments on embryo mortality was assessed using the chi-square test. Values were considered to be significantly different at p Ͻ 0.05. All results are presented as the mean Ϯ standard deviation (n), unless stated otherwise.
RESULTS
Embryo mortality for the control injections was 69%, compared to 77%, 60%, and 62% for PCB 77, PCB 153, and PCB 180, respectively (Table 1) . Temporal trends in PCB concentrations identified in the different tissues during the last week of development were very similar for all PCBs tested (Fig. 1) . Whereas PCB levels in the liver and carcasses of the animals increased significantly during the last week of embryonic development, PCB concentrations in brain tissue remained at an unaltered, low level. Liver concentrations were consistently two-to fourfold higher than the levels in the carcass homogenate.
The relative uptake of PCB 77 by the embryos was significantly higher than the uptake of PCB 153 at day 20 and the uptake of PCB 180 at days 20 and 21 (Table 2) . However, the 20-fold difference in dose between the dioxin-like PCB 77 and the other congeners makes it difficult to directly compare these results. No significant differences were observed between the uptake of PCB 153 and PCB 180 (Table 2) . Although a small concentration difference was noted between the PCB 153 (9.8 g/100 l) and PCB 180 (10.9 g/100 l) dosing solutions, tissue concentrations of these PCBs were not significantly different at any sampling date (Fig. 1) . A considerable amount of PCBs was still in the yolk at day 20 of incubation ( Table 2 ). The presence of HO-PCB metabolites in liver samples of the chicken embryos collected on days 18 and 20 was investigated, but none were detected.
Lipid analysis revealed that liver tissue of chicken embryos had a higher lipid content than brain tissue and that the lipid content of both organs increased between days 13 and 21 of incubation (Table 3 ). The neutral fraction of lipids represented about half the lipid weight of both organs at day 13, but their contribution to the total amount of liver lipids increased drastically during the last week of embryonic development.
DISCUSSION
The embryotoxicity of PCBs to birds has been studied primarily by direct injection of the compounds in the eggs and subsequent monitoring of embryo mortality and hatching success [9] . From experience (V.M. Darras, unpublished data), we know that approximately 15% of untreated Ross eggs can be expected to be unfertilized or to develop abnormally. It generally is accepted that dioxin-like PCBs, such as PCB 77, exhibit a considerably higher acute toxicity to bird embryos than nondioxin-like congeners [15] . Independent of the PCB administered, we observed a high rate of embryo mortality (Table 1) in all treated groups (range, 60-77%), including the control group, which indicates the severe burden that is caused by the injection itself. In accordance with the results of earlier studies [9] , we noticed that embryo mortality can be decreased substantially by injecting the eggs at a later stage (results not shown). Because PCBs are transferred from the mother to the offspring under natural conditions, embryos are exposed to PCBs from the first day of their existence. Therefore, it was decided to inject all the eggs before incubation in the present study.
Only a few studies have previously examined the developmental uptake of PCBs by chicken embryos. Bush et al. [16] added the commercial mixture Aroclor 1254 (Monsanto, St. Louis, MO, USA) to the drinking water of laying hens and studied the PCB concentrations in the eggs and offspring of these animals. Those authors found no apparent selective congener uptake by the embryo while absorbing yolk material. J. Maervoet et al. More recently, Bargar et al. [10] injected laying hens subcutaneously with three structurally related PCBs (PCB 105, 156, and 189), whereas de Roode and van den Brink [11] injected Aroclor 1254 directly into fertilized eggs. Both research groups observed a gradual uptake of PCBs by the embryo, but they did not investigate the uptake after hatching or the accumulation of PCBs in individual organs. Our results confirm this gradual PCB uptake, which appears to be very similar for the three investigated congeners. Polychlorinated biphenyl concentrations in the homogenate of the embryo carcasses increased exponentially during the last week of development (Fig. 1) . This exponential accumulation of the lipophilic PCBs is not surprising, because it coincides with the periods of both greatest embryonic growth and greatest lipid absorption. Before the 12th day of chicken development, only small amounts of lipids are absorbed from the yolk, and the embryo relies mainly on carbohydrate and protein metabolism for its energy needs. Thereafter, the lipid transfer to the embryo increases considerably between days 13 and 20 of development [17, 18] . In the present study, the corresponding concentrations of PCB 153 and PCB 180 in the various tissues were not significantly different at any test date (Fig.  1) . Respectively, 18% and 23% of the injected doses of PCB 153 and PCB 180 were detected in the embryo carcasses on day 20 of development (Table 2) . These results are almost identical to the findings of the earlier studies mentioned above [10, 11] . On day 20, de Roode and van den Brink [11] measured 18% of the injected amount of Aroclor 1254 in the embryos, whereas Bargar et al. [10] concluded that 80% of the chemical burden within the chicken eggs remained external to the embryos until this stage of development. Because the metabolic capacity of chicken embryos for PCBs is thought to be very limited (no PCB metabolites were detected in the present study as well), de Roode and van den Brink [11] suggested that the remainder of PCBs could be found in the yolk, but they did not confirm this with experimental data. Because we could only recover a limited amount of the injected PCBs in the carcasses of the hatched chicks at day 21 (Table 2) , the remaining yolk, collected on day 20 of incubation, also was investigated. We found that the PCBs in the yolk at day 20 accounted for approximately the increase in PCB concentration of the carcasses between days 20 and 21 (Table 2) , which can be explained by the fact that the residual yolk is withdrawn into the body cavity of the chick when it hatches. Still, although we thus obtain results similar to those of other research groups, it remains unclear where the remainder of the PCBs is located.
We found the relative uptake of PCB 77 in the embryos to be significantly higher than the absorption of the other congeners (Table 2) . However, it must be noted that the combined recovery of this congener in the carcass and yolk on day 20 was higher than the recovery of the other PCBs. Moreover, because of the high toxicity of this dioxin-like congener, PCB 77 was injected at a 20-fold lower dose than the other compounds, which makes it nearly impossible to compare these figures directly. Therefore, we cannot conclude from these results that a structure-dependent uptake of PCBs occurs from [11] did not observe any significant dose-related influence on PCB uptake, nor did they report a difference in the uptake of individual congeners. And although Bargar et al. [10] described uptake variability between PCB 105, PCB 156, and PCB 189 early in development, they also concluded that PCB profiles in the yolk and embryo were similar at day 20. Polychlorinated biphenyl levels in the liver samples revealed an analogous, exponential increase during the final week of chicken embryo development (Fig. 1) . Mean liver concentrations (expressed per g wet wt) were consistently twoto fourfold higher compared to mean PCB levels in the carcasses. Being lipophilic compounds, PCBs are thought to distribute from the blood to various body compartments, where they accumulate according to the lipid content of these tissues [19] . As a result, high hepatic PCB levels can be expected, because the liver has a relatively high lipid content (Table 3) and a high blood flow rate. Furthermore, the liver is a depot organ for PCBs and represents a major target organ for some of the adverse effects induced by these chemicals [2, 19, 20] .
Comparative tissue PCB distribution studies in different animals and humans have shown that PCBs accumulate in the brain to a much lesser extent, which is as expected when one considers the lipid content of this tissue [21] [22] [23] [24] [25] [26] . Our results reinforce this observation by showing that PCB levels in the chicken embryo brain are low compared to liver concentrations. Whereas the lipid content of liver was two-to threefold higher than that of brain tissue, hepatic PCB concentrations were approximately 20-fold higher around hatching (Table 3) . Interestingly, we noticed that PCB concentrations in brain tissue did not significantly increase between days 13 and 21 ( Fig.  1) , suggesting that the brain is already protected against exposure at this early stage of development. Both the action of the blood-brain barrier and the particular lipid composition of the brain have been suggested as possible explanations for this phenomenon.
The blood-brain barrier is composed of capillary cells that isolate, to a certain extent, the brain from the periphery [27] . Because of the presence of tight junctions, specific enzymes, and efflux pumps, the vessel walls are fairly impermeable. It remains a matter of debate at what time the blood-brain barrier of chickens can be considered to be functional. The first tight junction strands are thought to appear around day 9 of incubation, and the blood-brain barrier matures between days 12 and 16 [27] [28] [29] . However, this does not imply that the barrier is complete, because the endothelial tight junctions are still composed only of simple networks of incomplete, poorly interconnected fibrils at hatching [29] . As a result of progressive interconnections of the fibrillary strands after birth, a very tangled network is formed, and the blood-brain barrier is completed. Compounds may enter the brain by passive diffusion or by transporter-mediated uptake. Being small, neutral, and lipophilic molecules, PCBs theoretically have ideal physicochemical properties to diffuse freely across biological membranes, such as the blood-brain barrier [30] . Furthermore, PCBs can be found in the brain of adult animals exposed to these compounds, indicating that they can cross a completed and fully functional blood-brain barrier [31, 32] . In the present study, however, PCB concentrations did not increase in the chicken embryo brain at a time when it was protected only by an incomplete blood-brain barrier and when PCB levels in other tissues were increasing exponentially.
Our results therefore seem to suggest that the distribution of PCBs to the organs of the embryos was related primarily to the lipid content and composition of these tissues. Recently, coefficients for partitioning between trioleoylglycerol and phosphatidylcholine were established for 20 xenobiotics in vitro, and it was revealed that PCBs have a much higher affinity for triglycerides than for phospholipids [33] . Furthermore, the liver of chicken embryos contains mainly neutral lipids, such as triglycerides and cholesterol esters, whereas brain lipids are composed primarily of phospholipids and free cholesterol [34, 35] (B.K. Speake, Avian Science Research Centre, Scottish Agricultural College, Ayr, UK, personal communication). Our results confirm this by showing that the neutral lipids represented a major fraction of the total amount of lipids in the liver on day 13 of incubation and that this contribution still increased considerably during the subsequent week (Table 3) . On the contrary, the relative weight of this fraction in brain tissue increased only slightly during this period. Taken together, our results and data from the literature seem to suggest that the difference between brain and liver accumulation of PCBs is related primarily to the different amount of neutral lipids in these organs and that the distribution of PCBs from the blood to the organs depends not only on the lipid content but also on the lipid composition of tissues.
Most of the PCBs detected in brain are ortho-substituted, noncoplanar congeners [21] [22] [23] [24] [25] [26] 32] . Tampal et al. [36] recently suggested that ortho-substituted PCBs are able to cross the blood-brain barrier but that coplanar PCBs are preferentially restricted from the brain. They hypothesized that coplanar PCBs were removed from the brain by the multidrug resistance transporter-1, a phosphorylated glycoprotein that functions as an efflux transporter and plays a very significant role in preventing the delivery of several drugs to the central nervous system [37] . Their experiments with PCB 77, PCB 153, and PCB 169 as well as with metabolites of PCB 77 showed no evidence to support this theory, however, and indicated that PCBs are not substrates for this transporter. Our results also did not reveal any obvious structure-related difference in brain accumulation between the coplanar PCB 77 and the orthosubstituted PCB 153 and PCB 180 (Fig. 1) . From acute-exposure experiments in rats [32, 38] , it was concluded that a preferential accumulation of congeners more likely results from the structure-related metabolism of PCB congeners. Kodavanti et al. [32] concluded that the congener-specific distribution of PCBs in blood, liver, and fat was qualitatively similar to that of brain regions. Because the commercial mixtures only contain very low amounts of the coplanar PCBs (PCB 77 maximum, 0.5% by wt; other PCBs, Ͻ0.03% by wt) [39] and these compounds generally are more readily metabolized than ortho-substituted congeners [40] , it would be logical that ortho-substituted congeners are the most prevalent PCBs detected in (brain) tissues. The metabolic capacity of the chicken embryos is thought to be very limited, which probably avoids the biotransformation of the coplanar PCB 77 in our study. Our observations thus may support the assumption that uptake of PCB congeners in the brain is not related to the planarity of the congener.
In conclusion, our results indicate that an injection on day 1 of incubation causes a severe burden for chicken embryos, but lethality can be decreased by injecting the eggs at a later time. We observed a gradual uptake of PCBs from the egg by the developing chicken embryo, resulting in relatively high liver and low brain concentrations. The different lipid compositions of brain tissue and liver tissue may, at least in part, explain the difference in PCB accumulation by these tissues. Low environmental concentrations of planar compounds and
